Video

A New Decade Of Outsourcing: What Can We Expect? - Advice from Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen

Source: Outsourced Pharma

Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.

Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

Here are excerpts from the opening comments of one of our speakers,Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen.

VIEW THE VIDEO!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)